# A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

> **NCT05493488** · PHASE2 · UNKNOWN · sponsor: **DermBiont, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Tinea Pedis

## Interventions

- **BIOLOGICAL:** DBI-001 Gel
- **BIOLOGICAL:** DBI-002 Gel
- **BIOLOGICAL:** Aqueous Gel

## Key facts

- **NCT ID:** NCT05493488
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-08
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05493488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05493488, "A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05493488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*